CCT251545   Click here for help

GtoPdb Ligand ID: 8945

PDB Ligand
Compound class: Synthetic organic
Comment: CCT251545 is a small molecule inhibitor of WNT signalling [2]. The molecular targets of CCT251545 are the protein kinases CDK8 and CDK19 [1]. This is a type I inhibitor, binding in a DMG-in mode.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 63.05
Molecular weight 421.17
XLogP 3.73
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cn1ncc(c1)c1ccc(cc1)c1cncc(c1N1CCC2(CC1)CCNC2=O)Cl
Isomeric SMILES Cn1ncc(c1)c1ccc(cc1)c1cncc(c1N1CCC2(CC1)CCNC2=O)Cl
InChI InChI=1S/C23H24ClN5O/c1-28-15-18(12-27-28)16-2-4-17(5-3-16)19-13-25-14-20(24)21(19)29-10-7-23(8-11-29)6-9-26-22(23)30/h2-5,12-15H,6-11H2,1H3,(H,26,30)
InChI Key LBFYQISQYCGDDW-UHFFFAOYSA-N
Bioactivity Comments
CCT251545 inhibits CDK8-mediated STAT1 phosphorylation in vitro in human colorectal cancer cell lines, and reverses experimental intestinal hyperplasia in WNT-dependent tumour models in vivo [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
cyclin dependent kinase 19 Primary target of this compound Hs Inhibitor Inhibition 8.6 pKd - 1
pKd 8.6 (Kd 2.54x10-9 M) [1]
Description: CDK19/cyclin C.
cyclin dependent kinase 8 Primary target of this compound Hs Inhibitor Inhibition 8.4 pKd - 1
pKd 8.4 (Kd 3.8x10-9 M) [1]
Description: CDK8/cyclin C.